RVU120
ryvu therapeutics
['aml,(-streamline),(-seamless),(-kamloops),(-dreamlike)', 'mds', 'rvu120 ', 'rvu120', 'hr-mds', 'aml,(-streamline),(-seamless),(-kamloops),(-latamleaders)', 'ryvutx']
hello frankfurt! we are on-site at #eha2023 to present, e.g., the updated data from the ongoing dose-escalation phase 1b trial of #rvu120 in aml &amp; hr-mds, showing promising evidence of anti-leukemic activity and a manageable safety profile as monotherapy. 
Ryvu Therapeutics is developing novel small molecule therapies that address clinical limitations of current treatments in oncology.